Early development of lactic acidosis with short term linezolid treatment in a renal recipient.
Lee
Y R
YR
Powell
N
N
Bonatti
H
H
Sawyer
R G
RG
Barroso
L
L
Pruett
T L
TL
Sifri
C D
CD
Volles
D
D
D000081:Acetamides / Q000009:adverse effects*; D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D000890:Anti-Infective Agents / Q000009:adverse effects*; D016971:Citrobacter freundii; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation; D000069349:Linezolid; D000077731:Meropenem; D008875:Middle Aged; D023303:Oxazolidinones / Q000009:adverse effects*; D013845:Thienamycins / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000276:immunology
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D013845:Thienamycins; D000077731:Meropenem; D000069349:Linezolid